Cecilia Marie Edström
Director/Board Member chez NEONODE INC.
Fortune : 5 600 $ au 31/03/2024
Profil
Ms. Cecilia Marie Edström is an Independent Director at BioArctic AB and an Independent Director at Neonode, Inc. She is on the Board of Directors at BioArctic AB, Neonode, Inc. and A3P Biomedical AB.
Ms. Edström was previously employed as a Chief Executive Officer & Director by Bactiguard Holding AB, a Non-Executive Director by MegaFon OJSC, a Senior Vice President & Head-Group Communications by TeliaSonera AB, an Independent Director by Bröderna Edstrand Group AB, a Senior Vice President & Head-Corporate Relations by Scania AB, and a Member-Governing Council by Stockholm Chamber of Commerce.
She also served on the board at Nordic Public Affairs AB and Bactiguard AB.
She received her undergraduate degree from Stockholm School of Economics.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NEONODE INC.
0,03% | 18/04/2023 | 4 000 ( 0,03% ) | 5 600 $ | 31/03/2024 |
Postes actifs de Cecilia Marie Edström
| Sociétés | Poste | Début |
|---|---|---|
| NEONODE INC. | Director/Board Member | 16/05/2022 |
| BIOARCTIC AB | Director/Board Member | 01/06/2023 |
A3P Biomedical AB
 A3P Biomedical AB Medical/Nursing ServicesHealth Services A3P Biomedical AB is a Swedish company that aims to improve the precision in prostate cancer diagnostics and treatment. A3P Biomedical is headquartered in Sweden and has subsidiaries in the country. The private company's lead product is Stockholm3, a blood test for early detection of aggressive prostate cancer. The test has been developed by scientists at Institutet and validated in clinical studies involving more than 80,000 men. A total of SEK 750 million has been invested in clinical research, product development, and market validation activities. The company sells Stockholm3 to healthcare providers through direct sales and distributors. | Director/Board Member | - |
Anciens postes connus de Cecilia Marie Edström
| Sociétés | Poste | Fin |
|---|---|---|
| BACTIGUARD HOLDING AB | Chief Executive Officer | 01/10/2021 |
Nordic Public Affairs AB
 Nordic Public Affairs AB Miscellaneous Commercial ServicesCommercial Services Nordic Public Affairs AB provides designs and implements public relations campaigns. The company was founded by Martina Lind and Johan Jakobsson and is headquartered in Stockholm, Sweden. | Director/Board Member | 01/05/2020 |
| MEGAFON | Director/Board Member | 01/09/2013 |
| TELIA COMPANY AB | Public Communications Contact | 01/08/2013 |
| BE GROUP AB | Director/Board Member | 26/04/2013 |
Formation de Cecilia Marie Edström
| Stockholm School of Economics | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| TELIA COMPANY AB | Communications |
| BE GROUP AB | Distribution Services |
| NEONODE INC. | Electronic Technology |
| BIOARCTIC AB | Health Technology |
| BACTIGUARD HOLDING AB | Health Technology |
| Entreprise privées | 6 |
|---|---|
Scania AB
 Scania AB Motor VehiclesConsumer Durables SCANIA AB engages in the manufacture of commercial vehicles, which include heavy trucks and buses, as well as diesel engines and general industrial appliances. It operates through the Vehicles and Services and Financial Services segments. The Vehicles and Services segment encompasses trucks, buses and engines, including the services associated with these products. The Financial Services segment offers financial solutions such as loan financing, lease contracts, and insurance solutions. The company was founded in 1891 and is headquartered in Sodertalje, Sweden. | Consumer Durables |
MegaFon PJSC
 MegaFon PJSC Wireless TelecommunicationsCommunications MegaFon PJSC engages in the provision of telecommunications services. It offers voice, mobile and fixed-line data transfer, wireless data and wireless broadband services, roaming, short message service, and value-added service, developing business solutions, and sales of mobile phones and other electronics. The company was founded on June 17, 1993 and is headquartered in Moscow, Russia. | Communications |
Bactiguard AB
 Bactiguard AB Medical DistributorsDistribution Services Bactiguard AB develops and supplies infection protection solutions to reduce the risk of hospital and healthcare related infections. Its product portfolio, Bactiguard Infection Protection, prevents bacterial adhesion and biofilm formation on medical devices. The firm's products include Infection Prevention Foley Catheter, Central Venous Catheter, and Endotracheal Tube. The company was founded by Nils Peder Christian Kinch on June 13, 2005 and is headquartered in Stockholm, Sweden. | Distribution Services |
Stockholm Chamber of Commerce
 Stockholm Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Stockholm Chamber of Commerce is a member of Swedish Chambers International, which is an umbrella organization for Swedish Chambers of Commerce abroad. The Chamber of Commerce in Stockholm provides contact information for those who are unsure of who to contact regarding their matter. The non-profit company is based in Stockholm, Sweden, and has subsidiaries in Sweden. The purpose of SCI is to strengthen the brand internationally, facilitate business for companies, and exchange experiences. | Commercial Services |
Nordic Public Affairs AB
Nordic Public Affairs AB Miscellaneous Commercial ServicesCommercial Services Nordic Public Affairs AB provides designs and implements public relations campaigns. The company was founded by Martina Lind and Johan Jakobsson and is headquartered in Stockholm, Sweden. | Commercial Services |
A3P Biomedical AB
A3P Biomedical AB Medical/Nursing ServicesHealth Services A3P Biomedical AB is a Swedish company that aims to improve the precision in prostate cancer diagnostics and treatment. A3P Biomedical is headquartered in Sweden and has subsidiaries in the country. The private company's lead product is Stockholm3, a blood test for early detection of aggressive prostate cancer. The test has been developed by scientists at Institutet and validated in clinical studies involving more than 80,000 men. A total of SEK 750 million has been invested in clinical research, product development, and market validation activities. The company sells Stockholm3 to healthcare providers through direct sales and distributors. | Health Services |
